Compugen CGEN
NASDAQ CGEN
$2.59 +0.03 (+1.17%)
As of: Sep 4, 2026 · 3:19 PM EDT

Compugen (CGEN) Gross Margin Growth (1y) (2010 - 2026)

Analysis

Compugen (CGEN) Gross Margin Growth (1y) (2010 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin Growth (1y) (Qtr)
1 Vertex Pharmaceuticals 138.43 Bn 130.58 Bn 2.84 Bn -93.00
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -91.00
3 Argenx Se 63.34 Bn 58.15 Bn 1.37 Bn 210.00
4 Moderna 57.98 Bn 52.85 Bn 52.00 Mn 1,966.00
5 Revolution Medicines 43.98 Bn 43.98 Bn - -
6 BeOne Medicines 39.92 Bn 34.82 Bn 1.53 Bn 228.00
7 Alnylam Pharmaceuticals 35.42 Bn 32.11 Bn 992.69 Mn -475.00
8 Royalty Pharma 28.42 Bn 27.58 Bn - -
9 Insmed 27.36 Bn 26.20 Bn 358.27 Mn 1,034.00
10 Compugen 241.50 Mn 155.89 Mn -92,000.00 2,892.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2,892.00
Mar 31, 2026 2,126.00
Dec 31, 2025 4,064.00
Sep 30, 2025 -6,624.00
Jun 30, 2025 -10,930.00
Mar 31, 2025 -2,294.00
Dec 31, 2016 -5,358.00
Sep 30, 2016 5,777.00
Jun 30, 2016 4,903.00
Mar 31, 2016 -1,263.00
Dec 31, 2015 260.00
Sep 30, 2015 -4,464.00
Jun 30, 2015 -2,263.00
Mar 31, 2015 -3,897.00
Dec 31, 2014 3,057.00
Sep 30, 2014 4,901.00
Jun 30, 2014 33,808.00
Mar 31, 2014 5,710.00
Dec 31, 2013 7,974.00
Sep 30, 2013 -6,158.00